Company / Income Tax
Amphstar Pharmaceuticals, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$25.5M
FY2025
5-year range
$20.6M / $31.8M
FY2021-FY2025
Trend
-14.0%
vs FY2024
Sector context
#36 of 204
Health Care
What the data says
Amphstar Pharmaceuticals, Inc.'s income tax of $26M is higher than 82% of companies in the Health Care sector (FY2025). Income Tax has fluctuated over the past 10 years, ranging from -$3M in FY2018 to $32M in FY2023.
Based on SEC 10-K filings.
$26M in FY2025 with a 5-year CAGR of +48.5%. Top quartile in the Health Care sector.
Improved from $32M to $26M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +2.8%
- 5-Year CAGR
- +48.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 204This company $25.5M Sector average $118.7M
▼
-78.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +48.5%, indicating consistent growth.
- In FY2025, income tax decreased 14.0% year-over-year.
- Ranks #36 out of 204 companies in the Health Care sector.
- Peak income tax was recorded in FY2023.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.5M | -14.0% |
| FY2024 | $29.7M | -6.8% |
| FY2023 | $31.8M | +35.6% |
| FY2022 | $23.5M | +13.8% |
| FY2021 | $20.6M | +482.8% |
| FY2020 | $3.5M | -74.2% |
| FY2019 | $13.7M | +520.2% |
| FY2018 | -$3.3M | -36.2% |
| FY2017 | -$2.4M | -149.9% |
| FY2016 | $4.8M | +163.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026